Intern – Global Supply Chain & Data Science jobs in United States
cer-icon
Apply on Employer Site
company-logo

Cytokinetics · 10 hours ago

Intern – Global Supply Chain & Data Science

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology. They are seeking a highly motivated Intern to join their Global Supply Chain & Data Science group, where the intern will enhance operational monitoring capabilities and deliver digital assets to improve logistics decision-making.

BiopharmaBiotechnologyHealth Care

Responsibilities

Engage with the Global Logistics function to enhance operational monitoring capabilities in the post-launch environment
Deliver digital assets which increase the speed of Logistics decision-making, shorten the time needed to identify logistics exceptions, and reduce manual effort in Logistics reporting
Serve Logistics stakeholders, with secondary responsibilities in Planning, Finance, Clinical Supply Chain, Procurement, and Change Management
Engage with the program management and portfolio team in order to properly register digital assets

Qualification

SQL scriptingTableauPythonRData modelingExcelAnalytical skillsProblem-solvingCommunication skillsCollaboration

Required

Pursuing BS degree in Supply Chain, Industrial Engineering, Data Science or related area
Proficient in data modeling using SQL; understanding of Python, R, or other scripting languages
Experience with Excel and Tableau, including data organization, basic calculations, and development of dashboards and visualizations is a bonus
Demonstrated ability to work collaboratively across teams and contribute to continuous improvement initiatives
Strong analytical and problem-solving skills with the ability to support projects and meet defined deliverables
Clear written and verbal communication skills, with the ability to summarize data and present information effectively

Company

Cytokinetics

twittertwittertwitter
company-logo
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

Funding

Current Stage
Public Company
Total Funding
$2.41B
Key Investors
Royalty PharmaDeerfieldVulcan
2025-09-16Post Ipo Debt· $650M
2024-05-22Post Ipo Equity· $550M
2024-05-22Post Ipo Debt· $50M

Leadership Team

leader-logo
Robert Blum
President & CEO
linkedin
leader-logo
Sung Lee
EVP & CFO
linkedin
Company data provided by crunchbase